Management of patients
with Viral Hemorrhagic fever
Tauseef Akhund Research
Officer Paediatric Department.
Agha Khan University
Karachi Pakistan
Introduction
Viral hemorrhagic fever (VHF) is
the illness caused by geographically restricted viruses. Many viruses cause this
illness but four viruses including Lassa, Marburg, Ebola, and Crimean-Congo
hemorrhagic fever (CCHF) has potential of presenting in outbreak and has
potential of person-to-person transmission. Among these four viruses, CCHF is
endemic in certain parts of Afghanistan & Northern Pakistan. In September &
October of each year we do get referral of patients with diagnostic possibility
of CCHF. Since most physicians have little or no experience with these viruses,
uncertainty often arises when VHF is diagnostic possibility.
These guidelines review the
clinical and epidemiologic features of CCHF, provide recommendations on
diagnosis, investigation, and care of patients, and suggest measures to prevent
secondary transmission.
Crimean-Congo Hemorrhagic
fever
CCHF virus is an enveloped,
single-stranded Bunyaviridae. Many wild and domestic animals act as reservoirs
for the virus, including cattle, sheep, goats, and hares. Ixodid (hard) ticks
act both as a reservoir, and vector for CCHF virus.
CCHF is endemic in Eastern
Europe, particularly Soviet Union, Northwest China, Central Asia, Indian
subcontinent, Middle East and Africa.
Transmission:
Humans become infected by being
bitten by ticks or by crushing ticks, often while working with domestic animals
or livestock. Contact with blood, secretions, or excretions of infected animals
or humans may also transmit infection. In endemic areas, the disease may occur
most often in the spring or summer
Nosocomial
Transmission is well described in reports from
Pakistan, Iraq, Dubai, and South Africa. Available evidence suggests that blood
and other body fluids are highly infectious, but simple precautions, such as
barrier nursing, effectively prevent secondary transmission.
Clinical
Features:
The incubation period is about
2-9 days. Initial symptoms include fever, headache, myalgia, arthralgia,
abdominal pain & vomiting. Sore throat, conjunctivitis, jaundice, photophobia,
and various sensory and mood alterations may develop. A patechial rash is common
and may precede a gross and obvious hemorrhagic diathesis. The estimated
case-fatality rate is 15-70%. Symptoms & signs supporting the diagnosis of VHF
are pharyngitis, conjunctivitis, and later hemorrhage & shock.
Laboratory
features: Deranged LFT, leucopenia,
thrombocytopenia, and anemia.
Diagnosis:
Suspected on basis of epidemiologic risk factors,
clinical features and non-specific laboratory abnormalities. Illness is
confirmed by isolating the virus by PCR from blood during the first week of
illness or by demonstrating IgM antibody or a fourfold rise in IgG. Antibody may
not appear in blood until the second week of illness.
Treatment:
Ribavirin 30 mg / kg loading dose then 16 mg/kg
q6h x 4 days then 8 mg/kg q6h x 6 days. Supportive care and may require
intensive care.
Prophylaxis
for high risk contacts is Ribavirin 600 mg po q6 h x 7 days
Approach
to a suspected case of VHF:
General
Principles;
· Case identification:
o
Patient should be
classified as probable if
-
Temperature of 101F (38.3C)
or greater for < 3 weeks duration
-
Bleeding diathesis without
predisposing factors for hemorrhagic manifestations
-
leucopenia or
thrombocytopenia
o
Patient should be
classified as possible if
-
Temperature of 101F (38.3C)
or greater for < 3 weeks duration
-
leucopenia
or thrombocytopenia
If clinician feels that VHF is
likely (probable) diagnosis, they should take two immediate steps
1.
Isolate the patient
2.
notify infection control service
All other patients
with possible diagnosis should be kept on standard blood and body fluid
precautions
Definition
of Contact A contact is a person who has been
exposed to an infected person or to an infected person’s
secretions within three weeks of the patient’s onset of illness.
Contact may be:
Casual
contacts are people on the same aero plane or in the same hotel. No special
attention is required.
Close
contacts are defined as those family members living with patient or health
Care workers coming
into close contact with patient blood and body fluids. When
the Diagnosis is
confirmed, they should be placed under surveillance for three
weeks.
High-risk
contacts are those with:
Mucous membrane contact with the
patient (kissing, sexual intercourse), health care worker who has done CPR,
intubations or line placement without precautions. Needle- stick or other
penetrating injury. These contacts should be placed under surveillance as soon
as VHF is considered to be a likely diagnosis in the index patient. Any contact
that develops a temperature 38.30C or higher or any other symptoms of
illness should be immediately isolated and treated as a VHF patient.
Ribavirin should be prescribed as post-exposure prophylaxis
for
High-risk contacts of
patients with CCHF
Isolation of patient with
suspected and confirmed VHF:
General principles:
ü
The patient should be
isolated in single room with adjoining anteroom if possible. The anteroom
should contain supplies for routine patient care as well as gloves, gowns and
mask
ü
If possible, the
patient’s room should be at negative air pressure
ü
Strict barrier nursing
techniques should be enforced. All persons should
wear disposable gloves, gowns, masks, and shoe covers. Double gloving is
recommended in actively bleeding patients.
-
Protective eye wear
should be worn for persons dealing with disoriented or uncooperative
patients or performing procedures that might involve the patients vomiting
or bleeding (for example inserting the nasogastric tube or intravenous or
arterial line).
-
Protective clothing should
be donned and removed in anteroom
-
Isolation signs
listing necessary precautions should be posted outside the anteroom
-
Hand washing
with antiseptic solution (betadine) before and after leaving the room
-
Soiled Linen should
be double bagged at the site of use and laundered with normal hot water
cycle with bleach. Gowns, gloves and mask should be worn by laundry worker
during handling the soiled items
-
Patient care equipment
e.g. thermometer, blood pressure apparatus stethoscope, should be dedicated
to the patient. All non-disposable autoclave able equipment should be
autoclaved after soaking in disinfectant
-
The number of staff &
visitors should be limited
-
Suitable disinfectant
solution include 0.5% sodium hypochlorite (10% aqueous solution of
household bleach), and phenolic disinfectants (0.5%-3%). Soap and detergents
can also inactivate these viruses and should be used liberally
Collecting
Specimens
-
Specimens from confirmed or suspected cases should be regarded as highly
infectious
-
All routine (UNIVERSAL)
precautions should be taken.
-
Specimens should be
collected in a tightly sealed, screw-top plastic container
-
Specimens and request form
should be labeled with the patient’s details.
-
Specimens and request form
should be flagged with BIOHAZARD sticker
-
The outside of each
container should be swabbed with disinfectant.
-
The specimens should be
double-bagged in secure, airtight and watertight bags that have been
similarly labeled.
Transporting and Packaging Specimens
-
The watertight, primary
container with the specimen (no greater than 50 ml)
-
Specimens should be wrapped
in sufficient absorbent material to soak up the contents if a breakage
occurs.
Specimens
Handling
of dead body:
The same precautions recommended
for clinicians and laboratory staff working with infected patients and specimens
must be followed. Double gloves caps and gowns, waterproof aprons, shoe covers,
and protective eye wear are required. All unnecessary handling of the body,
including embalming should be avoided. The corpse should be placed in airtight
bag and cremated or buried immediately.